Literature DB >> 25726514

Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study.

Søren Dalsgaard1, Søren Dinesen Østergaard2, James F Leckman3, Preben Bo Mortensen4, Marianne Giørtz Pedersen5.   

Abstract

BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a common mental disorder associated with factors that are likely to increase mortality, such as oppositional defiant disorder or conduct disorder, criminality, accidents, and substance misuse. However, whether ADHD itself is associated with increased mortality remains unknown. We aimed to assess ADHD-related mortality in a large cohort of Danish individuals.
METHODS: By use of the Danish national registers, we followed up 1·92 million individuals, including 32,061 with ADHD, from their first birthday through to 2013. We estimated mortality rate ratios (MRRs), adjusted for calendar year, age, sex, family history of psychiatric disorders, maternal and paternal age, and parental educational and employment status, by Poisson regression, to compare individuals with and without ADHD.
FINDINGS: During follow-up (24·9 million person-years), 5580 cohort members died. The mortality rate per 10,000 person-years was 5·85 among individuals with ADHD compared with 2·21 in those without (corresponding to a fully adjusted MRR of 2·07, 95% CI 1·70-2·50; p<0·0001). Accidents were the most common cause of death. Compared with individuals without ADHD, the fully adjusted MRR for individuals diagnosed with ADHD at ages younger than 6 years was 1·86 (95% CI 0·93-3·27), and it was 1·58 (1·21-2·03) for those aged 6-17 years, and 4·25 (3·05-5·78) for those aged 18 years or older. After exclusion of individuals with oppositional defiant disorder, conduct disorder, and substance use disorder, ADHD remained associated with increased mortality (fully adjusted MRR 1·50, 1·11-1·98), and was higher in girls and women (2·85, 1·56-4·71) than in boys and men (1·27, 0·89-1·76).
INTERPRETATION: ADHD was associated with significantly increased mortality rates. People diagnosed with ADHD in adulthood had a higher MRR than did those diagnosed in childhood and adolescence. Comorbid oppositional defiant disorder, conduct disorder, and substance use disorder increased the MRR even further. However, when adjusted for these comorbidities, ADHD remained associated with excess mortality, with higher MRRs in girls and women with ADHD than in boys and men with ADHD. The excess mortality in ADHD was mainly driven by deaths from unnatural causes, especially accidents. FUNDING: This study was supported by a grant from the Lundbeck Foundation.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25726514     DOI: 10.1016/S0140-6736(14)61684-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  160 in total

1.  [The German research network for mental disorders].

Authors:  M Bauer; T Banaschewski; A Heinz; I Kamp-Becker; A Meyer-Lindenberg; F Padberg; M A Rapp; R Rupprecht; F Schneider; T G Schulze; H-U Wittchen
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

2.  Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.

Authors:  M Riera; X Castells; A Tobias; R Cunill; L Blanco; D Capellà
Journal:  Psychopharmacology (Berl)       Date:  2017-06-19       Impact factor: 4.530

3.  Effects of Integrated Brain, Body, and Social (IBBS) intervention on ERP measures of attentional control in children with ADHD.

Authors:  Stephanie D Smith; Michael J Crowley; Anne Ferrey; Kathleen Ramsey; Bruce E Wexler; James F Leckman; Denis G Sukhodolsky
Journal:  Psychiatry Res       Date:  2019-06-17       Impact factor: 3.222

4.  Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts.

Authors:  Zheng Chang; Patrick D Quinn; Lauren O'Reilly; Arvid Sjölander; Kwan Hur; Robert Gibbons; Henrik Larsson; Brian M D'Onofrio
Journal:  Biol Psychiatry       Date:  2019-12-13       Impact factor: 13.382

5.  Association of Exposure to Diethylstilbestrol During Pregnancy With Multigenerational Neurodevelopmental Deficits.

Authors:  Marianthi-Anna Kioumourtzoglou; Brent A Coull; Éilis J O'Reilly; Alberto Ascherio; Marc G Weisskopf
Journal:  JAMA Pediatr       Date:  2018-07-01       Impact factor: 16.193

6.  Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.

Authors:  Chris Bushe; Esther Sobanski; David Coghill; Lovisa Berggren; Katrien De Bruyckere; Sami Leppämäki
Journal:  CNS Drugs       Date:  2016-04       Impact factor: 5.749

7.  Characteristics of undiagnosed children with parent-reported ADHD behaviour.

Authors:  Kathrine Bang Madsen; Mette Holmelin Ravn; Jon Arnfred; Jørn Olsen; Charlotte Ulrikka Rask; Carsten Obel
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-07-21       Impact factor: 4.785

8.  Attention-deficit/hyperactivity disorder and brain metabolites from proton magnetic resonance spectroscopy: a systematic review and meta-analysis protocol.

Authors:  Marcos Vinícius Vidor; Alana Castro Panzenhagen; Alexandre Ribeiro Martins; Renata Basso Cupertino; Cibele Edom Bandeira; Luis Augusto Rohde; Diego Luiz Rovaris; Claiton Henrique Dotto Bau; Eugênio Horácio Grevet
Journal:  Trends Psychiatry Psychother       Date:  2021-02-15

9.  In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children.

Authors:  Hong Liang; Jianping Chen; Maohua Miao; Jakob Christensen; Søren Dalsgaard; Wei Yuan; Jiong Li
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-02-09       Impact factor: 4.785

10.  Nature and prevalence of combinations of mental disorders and their association with excess mortality in a population-based cohort study.

Authors:  Oleguer Plana-Ripoll; Katherine L Musliner; Søren Dalsgaard; Natalie C Momen; Nanna Weye; Maria K Christensen; Esben Agerbo; Kim Moesgaard Iburg; Thomas Munk Laursen; Preben Bo Mortensen; Carsten Bøcker Pedersen; Liselotte Vogdrup Petersen; Damian F Santomauro; Bjarni J Vilhjálmsson; Harvey A Whiteford; John J McGrath
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.